Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Universität des Saarlandes
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Boehringer Ingelheim
City of Hope Medical Center
City of Hope Medical Center
Stanford University
University of Nebraska
University of Nebraska
University of Nebraska
Stanford University
University of Nebraska
University of Nebraska
University of Nebraska
Children's Oncology Group
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Atara Biotherapeutics
Roswell Park Cancer Institute
Stanford University
National Heart, Lung, and Blood Institute (NHLBI)
Rutgers, The State University of New Jersey
Northwestern University
Northwestern University
Spectrum Pharmaceuticals, Inc
Gilead Sciences
Gilead Sciences
Roswell Park Cancer Institute
Universität des Saarlandes
City of Hope Medical Center
Universität des Saarlandes
Universität des Saarlandes
Barbara Ann Karmanos Cancer Institute
Takeda
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
German High-Grade Non-Hodgkin's Lymphoma Study Group
Fred Hutchinson Cancer Center